Table 3 Mean variables at 12 weeks of treatment
Variables | Placebo (N=20) | Carnosine (N=20) | P value |
|---|---|---|---|
Body weight (kg) | 72.54±14.7 | 81.34±18.9 | 0.117 |
Body mass index (kg/m2) | 28.18±5.0 | 30.12±5.6 | 0.268 |
Systolic blood pressure (mmHg) | 133.35±16.5 | 130.9±13.6 | 0.611 |
Diastolic blood pressure (mmHg) | 76.2±7.9 | 78.9±11.7 | 0.763 |
BUN (mg/dL) | 18.89±5.6 | 16.06±5.9 | 0.217 |
Creatinine (mg/dL) | 0.895±0.03 | 0.896±0.3 | 0.832 |
GFR (mL/min/1.73m2) | 78.34±23.6 | 85.78±20.2 | 0.434 |
Fasting plasma glucose (mg/dL) | 156.85±70.2 | 151.9±47.5 | 0.171 |
HemoglobinA1C (%) | 7.86±1.8 | 7.48±1.3 | 0.716 |
LDL (mg/dL) | 102.59±48.1 | 91.5±35.2 | 0.656 |
HDL (mg/dL) | 51.17±13.2 | 46.89±9.2 | 0.404 |
Cholesterol (mg/dL) | 166.43±51.6 | 147.6±35.1 | 0.383 |
Triglyceride (mg/dL) | 150.22±77.1 | 157.02±71.7 | 0.926 |